Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

SABCS 2017: The latest in CDK inhibition in breast cancer

Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz
SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )
10 Dec 2017

Autologous haematopoietic cell transplant for mantle cell lymphoma

Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA
Autologous haematopoietic cell transplant for mantle cell lymphoma ( Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA )
9 Dec 2017

Dexamethasone and the UKALL 2011 trial

Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Dexamethasone and the UKALL 2011 trial ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
9 Dec 2017

Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
9 Dec 2017

Postmenopausal women who lose weight may have reduced breast cancer risk

Prof Rowan Chlebowski - City of Hope, Duarte, USA
Postmenopausal women who lose weight may have reduced breast cancer risk ( Prof Rowan Chlebowski - City of Hope, Duarte, USA )
9 Dec 2017

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA
CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )
9 Dec 2017

Reducing risk of breast cancer recurrence and death with increased dose density

Prof Richard Gray - University of Oxford, Oxford, UK
Reducing risk of breast cancer recurrence and death with increased dose density ( Prof Richard Gray - University of Oxford, Oxford, UK )
9 Dec 2017

Breast cancer therapy resistance mediated by FGFR amplification

Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA
Breast cancer therapy resistance mediated by FGFR amplification ( Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA )
9 Dec 2017

The significance of CEACAM 5 in metastases of triple negative breast cancer

Emily Powell - MD Anderson Cancer Center, Houston, USA
The significance of CEACAM 5 in metastases of triple negative breast cancer ( Emily Powell - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

Results of the MONALEESA 7 trial

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA
Results of the MONALEESA 7 trial ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

The REACT trial: Celecoxib vs placebo for primary breast cancer

Prof Charles Coombes - Imperial College School of Medicine, London, UK
The REACT trial: Celecoxib vs placebo for primary breast cancer ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )
9 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation